N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang et al., A novel coronavirus from patients with pneumonia in China, N Engl J Med, vol.382, pp.727-760, 2019.

C. Lai, T. Shih, W. Ko, H. Tang, and P. Hsueh, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges, Int J Antimicrob Agents, vol.2020, p.105924

C. A. Devaux, J. Rolain, P. Colson, and D. Raoult, New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?, Int J Antimicrob Agents, 2020.
URL : https://hal.archives-ouvertes.fr/hal-02517890

M. Wang, R. Cao, L. Zhang, X. Yang, J. Liu et al., Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res, vol.30, pp.269-71, 2020.

P. Colson, J. Rolain, and D. Raoult, Chloroquine for the 2019 novel coronavirus SARS-CoV-2, Int J Antimicrob Agents, vol.2020, p.105923
URL : https://hal.archives-ouvertes.fr/hal-02504553

W. Ko, J. Rolain, N. Lee, P. Chen, C. Huang et al., Remdesivir for SARS-CoV-2 pneumonia, Int J Antimicrob Agents, 2020.

J. Zhang, X. Ma, F. Yu, J. Liu, F. Zou et al., Teicoplanin potently blocks the cell entry of 2019-nCoV, 2020.

N. Zhou, T. Pan, J. Zhang, Q. Li, X. Zhang et al., Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome/lysosome and block the entry of Ebola virus, Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV), J Biol Chem, vol.291, pp.9218-9250, 2016.

P. Colson and D. Raoult, Fighting viruses with antibiotics: an overlooked path, Int J Antimicrob Agents, vol.4, pp.34-43, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01455802

T. Pan, N. Zhou, and H. Zhang, Use of teicoplanin anti-Middle East respiratory syndrome coronavirus. WIPO PatentScope, 2015.